Search Results - "Kushner, Max H"

An AIB1 Isoform Alters Enhancer Access and Enables Progression of Early-Stage Triple-Negative Breast Cancer by Sharif, Ghada M, Campbell, Moray J, Nasir, Apsra, Sengupta, Surojeet, Graham, Garrett T, Kushner, Max H, Kietzman, William B, Schmidt, Marcel O, Pearson, Gray W, Loudig, Olivier, Fineberg, Susan, Wellstein, Anton, Riegel, Anna T

“…AIB1Δ4 is an N-terminally truncated isoform of the oncogene amplified in breast cancer 1 (AIB1) with increased expression in high-grade human ductal carcinoma…”
Get full text

PIM kinase inhibitor AZD1208 for treatment of MYC-driven prostate cancer by Kirschner, Austin N, Wang, Jie, van der Meer, Riet, Anderson, Philip D, Franco-Coronel, Omar E, Kushner, Max H, Everett, Joel H, Hameed, Omar, Keeton, Erika K, Ahdesmaki, Miika, Grosskurth, Shaun E, Huszar, Dennis, Abdulkadir, Sarki A

“…PIM1 kinase is coexpressed with c-MYC in human prostate cancers (PCs) and dramatically enhances c-MYC-induced tumorigenicity. Here we examine the effects of a…”
Get full text

Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression by Kushner, Max H, Ory, Virginie, Graham, Garrett T, Sharif, Ghada M, Kietzman, William B, Thevissen, Sophia, Yuan, Meng, Schmidt, Marcel O, Wellstein, Anton, Riegel, Anna T

“…Transcription factors critical for the transition of normal breast epithelium to ductal carcinoma in situ (DCIS) and invasive breast cancer are not clearly…”
Get full text

Short- and Long-Term Effects of CDK4/6 Inhibition on Early-Stage Breast Cancer by Kietzman, William B, Graham, Garrett T, Ory, Virginie, Sharif, Ghada M, Kushner, Max H, Gallanis, Gregory T, Kallakury, Bhaskar, Wellstein, Anton, Riegel, Anna T

“…CDK4/6 inhibitors are used in the treatment of advanced estrogen receptor (ER)(+) breast cancer. Their efficacy in ER(-) and early-stage breast cancer is…”
Get full text